HLN (Haleon) Research & Development : $382 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Haleon's Research & Development for the three months ended in Sep. 2024 was $101 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $382 Mil.

Haleon Research & Development Historical Data

The historical data trend for Haleon's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Research & Development Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

408.60

341.76

365.41

393.67

376.74

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Research & Development	Get a 7-Day Free Trial												118.99	90.22	92.88	100.53	98.61

Haleon Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $382 Mil.

Haleon (NYSE:HLN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Haleon Research & Development Related Terms

Thank you for viewing the detailed overview of Haleon's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN1:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.